GlaxoSmithKline Consumer Nigeria PLC 1 Industrial Avenue, Ilupeju
RC 8726
PMB 21218 Ikeja, Lagos
Tel: +234 (01) 2711000, (01) 3242900www.gsk.com/ng
Corporate Actions Announcement
GlaxoSmithKline Consumer Nigeria Plc hereby announce as follows:
Period Ended | 31st December 2021 |
Proposed Dividend | A Dividend of N0.45 kobo per 50 kobo ordinary share from the profit for the year ended 31st December 2021 subject to appropriate withholding tax and approval at the Annual General Meeting will be paid to Shareholders whose names appear in the Register of Members as the close of business on the 22nd April, 2022 |
Closure of Register | The Register of Shareholders will be closed from Monday, 25th April 2022 to Thursday, 5th May 2022 (both dates inclusive). |
Qualification Date | 22nd April 2022 |
Payment Date | On 27th May 2022, dividends will be paid electronically to Shareholders whose names appear in the Register of Members as at 22nd April 2022, and who have completed the e-dividend registration and mandated the Registrar to pay their dividends directly into their Bank accounts. |
E-Dividend Registration | Shareholders who are yet to complete the e-dividend registration are advised to download the Registrar's E-Dividend Mandate Activation Form which is available on their website:www.gtlregistrars.com,complete and submit to the Registrar or their respective Banks. |
Unclaimed Dividend Warrants and Share Certificates | Shareholders with dividend warrants and share certificates that have remained unclaimed, or are yet to be presented for payment or returned for validation are advised to complete the e-dividend registration or contact the Registrar |
Date of Annual General Meeting | The Company's Annual General Meeting will be held at GSK House, 1, Industrial Avenue, Ilupeju, Lagos on Thursday 26th May, 2022 |
Registrar | The details of our Registrars are: Greenwich Registrars & Data Solutions Limited, 274, Murtala Muhammed Way, Yaba. Phone Number: 01-2793160-2 Email address:info@gtlregistrars.com and website:www.gtlregistrars.com |
Investor Relations | Tel. 01-2711000 and Email:ng.investors@gsk.com |
Dated this 23rd day of March 2022
Frederick Ichekwai
Company Secretary
Agbara Factory: Km 32, Igbesa Road, Agbara, Ogun State. Tel: +234 (01) 2918000.Email:Customer_ch_nigeria@gsk.com
Directors: Mr. Edmund Onuzo, Chairman; Mr. Kunle Oyelana, Managing Director; Mr. Samuel Kuye; Mr. Mark Pfister (South African), Executive Director, Consumer Healthcare; Mr. Bosco Kirugi (Kenyan), Finance Director; Mrs. Oludewa Edodo-Thorpe; Mr. Oussama Abbas (French); Ms. Amina Salihu
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Glaxo Smithkline Consumer Nigeria plc published this content on 06 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 April 2022 13:21:01 UTC.